$WNDW
SolarWindow Technologies, Inc.

2024 Q1 Form 10-Q Financial Statement

#000117184324000236 Filed on January 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $369.3K $451.5K
YoY Change 2.7% -15.66%
% of Gross Profit
Research & Development $132.6K $116.7K
YoY Change -26.44% -49.88%
% of Gross Profit
Depreciation & Amortization $3.060K $3.594K
YoY Change -14.76% -8.48%
% of Gross Profit
Operating Expenses $502.0K $568.2K
YoY Change -7.03% -26.03%
Operating Profit -$502.0K -$568.2K
YoY Change -7.03% -26.03%
Interest Expense $60.40K $68.70K
YoY Change 21.77% 63.49%
% of Operating Profit
Other Income/Expense, Net $60.40K $68.70K
YoY Change 21.79% 63.47%
Pretax Income -$441.6K -$499.5K
YoY Change -9.94% -31.21%
Income Tax
% Of Pretax Income
Net Earnings -$447.0K -$501.4K
YoY Change -15.29% -30.96%
Net Earnings / Revenue
Basic Earnings Per Share -$0.02 -$0.01
Diluted Earnings Per Share -$0.02 -$0.01
COMMON SHARES
Basic Shares Outstanding 53.20M shares 53.20M shares
Diluted Shares Outstanding 53.20M shares 53.20M shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.199M $5.435M
YoY Change -26.42% -28.56%
Cash & Equivalents $1.199M $135.0K
Short-Term Investments $4.000M $5.300M
Other Short-Term Assets $172.8K $437.7K
YoY Change -35.12% 97.29%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.372M $5.873M
YoY Change -26.73% -24.99%
LONG-TERM ASSETS
Property, Plant & Equipment $1.311M $1.312M
YoY Change -0.9% -1.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.311M $1.312M
YoY Change -0.9% -1.08%
TOTAL ASSETS
Total Short-Term Assets $5.372M $5.873M
Total Long-Term Assets $1.311M $1.312M
Total Assets $6.683M $7.184M
YoY Change -22.78% -21.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.59K $167.3K
YoY Change -71.45% 3.71%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $225.6K $331.6K
YoY Change -1.47% 45.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $225.6K $331.6K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $225.6K $331.6K
YoY Change -1.47% 45.34%
SHAREHOLDERS EQUITY
Retained Earnings -$76.73M -$75.88M
YoY Change 3.36% 2.95%
Common Stock $53.20K $53.20K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.457M $6.853M
YoY Change
Total Liabilities & Shareholders Equity $6.683M $7.184M
YoY Change -22.78% -21.53%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$447.0K -$501.4K
YoY Change -15.29% -30.96%
Depreciation, Depletion And Amortization $3.060K $3.594K
YoY Change -14.76% -8.48%
Cash From Operating Activities -$233.9K -$557.6K
YoY Change -56.87% 18.78%
INVESTING ACTIVITIES
Capital Expenditures $1.950K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $1.300M $200.0K
YoY Change -121.67%
Cash From Investing Activities $1.298M $200.0K
YoY Change -121.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -233.9K -$557.6K
Cash From Investing Activities 1.298M $200.0K
Cash From Financing Activities
Net Change In Cash 1.064M -$357.6K
YoY Change -116.27% -23.91%
FREE CASH FLOW
Cash From Operating Activities -$233.9K -$557.6K
Capital Expenditures $1.950K
Free Cash Flow -$235.9K
YoY Change -56.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Revenues
Revenues
usd
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001071840
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 wndw Redemption Of Shortterm Investments
RedemptionOfShorttermInvestments
usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2023Q4 wndw Disposal Group Including Discontinued Operation Research And Development Expense
DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Interest Income
DisposalGroupIncludingDiscontinuedOperationInterestIncome
usd
CY2023Q4 dei Document Type
DocumentType
10-Q
CY2023Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q4 dei Document Period End Date
DocumentPeriodEndDate
2023-11-30
CY2023Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 dei Entity File Number
EntityFileNumber
333-127953
CY2023Q4 dei Entity Registrant Name
EntityRegistrantName
SOLARWINDOW TECHNOLOGIES, INC.
CY2023Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-3509694
CY2023Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
9375 E. Shea Blvd.
CY2023Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 107-B
CY2023Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
CY2023Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2023Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85260
CY2023Q4 dei City Area Code
CityAreaCode
800
CY2023Q4 dei Local Phone Number
LocalPhoneNumber
213-0689
CY2023Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q4 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53198399 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
135020 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
492610 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
5300000 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
5500000 usd
CY2023Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
103633 usd
CY2023Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
56698 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
320319 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
241688 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
13775 usd
CY2023Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
13522 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
5872746 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
6304498 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
128721 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
125127 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1311688 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1315282 usd
CY2023Q4 us-gaap Assets
Assets
7184434 usd
CY2023Q3 us-gaap Assets
Assets
7619780 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
167336 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
114092 usd
CY2023Q4 wndw Related Party Payables
RelatedPartyPayables
24583 usd
CY2023Q3 wndw Related Party Payables
RelatedPartyPayables
37025 usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
139646 usd
CY2023Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
136109 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
331565 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
287226 usd
CY2023Q4 us-gaap Liabilities
Liabilities
331565 usd
CY2023Q3 us-gaap Liabilities
Liabilities
287226 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53198399 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53198399 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53198399 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53198399 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
53198 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
53198 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82758599 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82735384 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-79687 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-78159 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75879241 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75377869 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6852869 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
7332554 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7184434 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7619780 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
451501 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
384484 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
116696 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
216566 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
568197 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
601050 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-568197 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-601050 usd
CY2023Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
68695 usd
CY2022Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
42013 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
68695 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
42013 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-499502 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-559037 usd
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1870 usd
CY2022Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-167120 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-501372 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-726157 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
1528 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
5431 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-502900 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-731588 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
CY2023Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
CY2022Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
CY2022Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.00
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.00
CY2022Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.00
CY2022Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.00
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53198399 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53198399 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53198399 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53198399 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
7332554 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
23215 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1528 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-501372 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6852869 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9574095 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
85200 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5431 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-726157 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8927707 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-499502 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-559037 usd
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1870 usd
CY2022Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-167120 usd
CY2023Q4 us-gaap Depreciation
Depreciation
3594 usd
CY2022Q4 us-gaap Depreciation
Depreciation
3927 usd
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23215 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
85200 usd
CY2023Q4 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
46935 usd
CY2022Q4 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
5327 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
78650 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-68051 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
55000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
39895 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-12442 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
64964 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-557590 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-469447 usd
CY2023Q4 wndw Redemption Of Shortterm Investments
RedemptionOfShorttermInvestments
200000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
200000 usd
CY2022Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-500 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-357590 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-469947 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
492610 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8077849 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
135020 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7607902 usd
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
5435020 usd
CY2023Q4 wndw Working Capital
WorkingCapital
5541181 usd
CY2022Q4 wndw Disposal Group Including Discontinued Operation Research And Development Expense
DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
16253 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
1870 usd
CY2023Q4 us-gaap Cash
Cash
135020 usd
CY2023Q3 us-gaap Cash
Cash
492610 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
5300000 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
5500000 usd
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
5435020 usd
CY2023Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
5992610 usd
CY2023Q4 wndw Short Term Investment Description
ShortTermInvestmentDescription
As of November 30, 2023, short-term investments consist of a 12-month $4,000,000 fixed-term deposit earning interest of 5.3%, and a 12-month $1,300,000 fixed term deposit earning interest of 4.25% purchased in February 2023 and which $200,000 was redeemed during the three months ended November 30, 2023.
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
1870 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
150876 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
167129 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Interest Income
DisposalGroupIncludingDiscontinuedOperationInterestIncome
9 usd
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1870 usd
CY2022Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-167120 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Prepaid And Other Assets Current
DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
13775 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Prepaid And Other Assets Current
DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
13522 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
13775 usd
CY2023Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
13522 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
13775 usd
CY2023Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
13522 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent
139646 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent
136109 usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
139646 usd
CY2023Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
136109 usd
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20849667 shares
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25346317 shares
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1440410 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1440410 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
128721 usd
CY2023Q3 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
125128 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1311688 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1315282 usd
CY2023Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3594 usd
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3927 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53198399 shares
CY2023Q4 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
22510 usd
CY2022Q4 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
70810 usd
CY2023Q4 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
705 usd
CY2022Q4 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
14390 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
23215 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
85200 usd
CY2023Q4 us-gaap Legal Fees
LegalFees
43750 usd
CY2022Q4 us-gaap Legal Fees
LegalFees
43750 usd

Files In Submission

Name View Source Status
wndw-20231130_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
wndw-20231130_def.xml Edgar Link unprocessable
0001171843-24-000236-index-headers.html Edgar Link pending
0001171843-24-000236-index.html Edgar Link pending
0001171843-24-000236.txt Edgar Link pending
0001171843-24-000236-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10q_011024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wndw-20231130.xsd Edgar Link pending
f10q_011024_htm.xml Edgar Link completed
wndw-20231130_lab.xml Edgar Link unprocessable
wndw-20231130_pre.xml Edgar Link unprocessable